| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.34 | 0.05 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.08 | 0.05 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.05 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.05 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.33 | 0.05 |